Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study.
Noda T, Takahashi H, Tei M, Nishida N, Hata T, Takeda Y, Ohue M, Wada H, Mizushima T, Asaoka T, Uemura M, Kobayashi S, Murata K, Satoh T, Doki Y, Eguchi H; Clinical Study Group of Osaka University (CSGO), Colorectal Group, and Hepato‐Biliary‐Pancreatic Group. Noda T, et al. Among authors: doki y. Ann Gastroenterol Surg. 2022 Oct 21;7(3):479-490. doi: 10.1002/ags3.12631. eCollection 2023 May. Ann Gastroenterol Surg. 2022. PMID: 37152774 Free PMC article.
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsuda S, Kitagawa Y, Okui J, Okamura A, Kawakubo H, Takemura R, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y. Matsuda S, et al. Among authors: doki y. Ann Surg. 2023 Aug 1;278(2):e234-e239. doi: 10.1097/SLA.0000000000005701. Epub 2022 Oct 29. Ann Surg. 2023. PMID: 36538635
[No title available]
[No authors listed] [No authors listed] PMID: 36611068
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer.
Matsuda C, Kudo T, Morimoto Y, Kagawa Y, Tei M, Ide Y, Miyoshi N, Takahashi H, Uemura M, Takemasa I, Satoh T, Mizushima T, Murata K, Doki Y, Eguchi H; Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MSCSGO). Matsuda C, et al. Among authors: doki y. Ann Gastroenterol Surg. 2022 Jul 15;7(1):81-90. doi: 10.1002/ags3.12600. eCollection 2023 Jan. Ann Gastroenterol Surg. 2022. PMID: 36643362 Free PMC article.
Neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma.
Yamada M, Tanaka K, Yamasaki M, Yamashita K, Makino T, Saito T, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y. Yamada M, et al. Among authors: doki y. Oncol Lett. 2022 Dec 20;25(2):58. doi: 10.3892/ol.2022.13644. eCollection 2023 Feb. Oncol Lett. 2022. PMID: 36644140 Free PMC article.
1,579 results